ChemicalBook >> CAS DataBase List >>NVP-BAW2881

NVP-BAW2881

CAS No.
861875-60-7
Chemical Name:
NVP-BAW2881
Synonyms
CS-2238;BAW2881;NVP-BAW2881;BAW2881 (NVP-BAW2881);NVP-BAW2881;NVP-BAW-2881;;NVP-BAW 2881;6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide;1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-;6-(2-amino-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethyl phenyl)amide;NVPBAW2881,inhibit,BAW 2881,NVP BAW2881,Vascular endothelial growth factor receptor,VEGFR,Inhibitor,NVP-BAW2881,BAW-2881,NVP-BAW-2881
CBNumber:
CB93133229
Molecular Formula:
C22H15F3N4O2
Molecular Weight:
424.38
MDL Number:
MFCD30343850
MOL File:
861875-60-7.mol
Last updated:2023-05-21 10:59:17

NVP-BAW2881 Properties

storage temp. Store at -20°C
solubility ≥42.4 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
form solid

NVP-BAW2881 price More Price(21)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 18910 BAW 2881 ≥98% 861875-60-7 1mg $44 2024-03-01 Buy
Cayman Chemical 18910 BAW 2881 ≥98% 861875-60-7 5mg $202 2024-03-01 Buy
Cayman Chemical 18910 BAW 2881 ≥98% 861875-60-7 10mg $384 2024-03-01 Buy
Cayman Chemical 18910 BAW 2881 ≥98% 861875-60-7 25mg $848 2024-03-01 Buy
TRC A630190 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide 861875-60-7 1mg $60 2021-12-16 Buy
Product number Packaging Price Buy
18910 1mg $44 Buy
18910 5mg $202 Buy
18910 10mg $384 Buy
18910 25mg $848 Buy
A630190 1mg $60 Buy

NVP-BAW2881 Chemical Properties,Uses,Production

Description

BAW 2881 is a vascular endothelial growth factor receptor (VEGFR) inhibitor (IC50s = 0.82, 0.037, and 0.42 μM for hVEGFR1, 2, and 3, respectively). It inhibits Tie2 and RET with IC50 values of 0.65 and 0.41 μM, respectively, but demonstrates IC50 values great than 10 μM toward a large panel of additional kinases. BAW 2881 was shown to block VEGF-A-induced proliferation, migration, and tube formation of human umbilical vein endothelial cells and lymphatic endothelial cells in vitro. In a mouse model of psoriasis, both oral and topical administration of BAW 2881 reduced psoriasis-like inflammation in ear skin. Topical application of BAW 2881 also reduced VEGF-A-induced vascular permeability and inhibited contact hypersensitivity reactions and UV-B-induced erythema in the skin of domestic pigs.

Uses

6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]-1-naphthalenecarboxamide is a selective vascular endothelial growth factor (VEGF) receptor inhibitor. VEGF receptors play important roles in angiogenesis and vascular permeability.

in vitro

previous study showed that baw2881 could inhibit a limited number of kinases including c-raf, b-raf, ret, abl, and tie-2 at submicromole ic50s. baw2881 could also inhibit the ligand induced autophosphorylation of ret, pdgfr, and kit kinases. moreover, low ic50 value (0.12 ± 0.06 nm) demonstrated that baw2881 remarkably abrogated vegf induced proliferation [1].

in vivo

in a psoriasis mouse model, baw2881 was able to reduce the number of blood and lymphatic vessels and infiltrating leukocytes in the skin, and normalize the epidermal architecture. baw2881 also showed strong anti-inflammatory effects in acute inflammation models. moreover, the pretreatment with topical baw2881 could significantly inhibit vegf-a-induced vascular permeability in the skin of both pigs and mice. in addition, it was found that the topical application of baw2881 was able to reduce the inflammatory response in pig skin caused by uv-b irradiation or by contact hypersensitivity reactions [2].

IC 50

1.0-4.3 nm for vegfr1-3

References

[1] bold g et al. a novel potent oral series of vegfr2 inhibitors abrogate tumor growth by inhibiting angiogenesis. j med chem. 2016 jan 14;59(1):132-46.
[2] halin c,fahrngruber h,meingassner jg,bold g,littlewood-evans a,stuetz a,detmar m. inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. am j pathol.2008 jul;173(1):265-77.

NVP-BAW2881 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 64)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289 contact@trustwe.com China 5738 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581 sales@chemhifuture.com China 3136 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054 trendseenbio@gmail.com China 11681 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501 product@acmec-e.com China 33349 58
Aladdin Scientific
+1-833-552-7181 sales@aladdinsci.com United States 57511 58

View Lastest Price from NVP-BAW2881 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
NVP-BAW2881 pictures 2019-12-23 NVP-BAW2881
861875-60-7
US $1.00 / g 1g 99.99% 200kg Career Henan Chemical Co
  • NVP-BAW2881 pictures
  • NVP-BAW2881
    861875-60-7
  • US $1.00 / g
  • 99.99%
  • Career Henan Chemical Co

NVP-BAW2881 Spectrum

NVP-BAW2881 BAW2881 BAW2881 (NVP-BAW2881) 6-((2-aminopyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide 6-(2-amino-pyrimidin-4-yloxy)naphthalene-1-carboxylic acid (3-trifluoromethyl phenyl)amide CS-2238 NVP-BAW2881;NVP-BAW-2881;;NVP-BAW 2881 1-Naphthalenecarboxamide, 6-[(2-amino-4-pyrimidinyl)oxy]-N-[3-(trifluoromethyl)phenyl]- NVPBAW2881,inhibit,BAW 2881,NVP BAW2881,Vascular endothelial growth factor receptor,VEGFR,Inhibitor,NVP-BAW2881,BAW-2881,NVP-BAW-2881 861875-60-7